
The comprehensive Thalassemia Program at Lurie Children’s cares for over 150 children and adults with all forms of thalassemia and is the largest thalassemia treatment center in the Midwest. Our Thalassemia Program is a nationally designated Thalassemia Care Center recognized by The Centers for Disease Control and Prevention.
Our specialists have extensive experience in treating all types of thalassemia and provide the highest quality care for our patients. From initial diagnosis to exploring treatment options, our care team is with you every step of the way.
The thalassemia patient population at Lurie Children’s Hospital is diverse, representing a variety of racial and ethnic groups from birth through late adulthood.
Why Choose Lurie Children's for Thalassemia Treatment?
We work to improve the health and well-being of patients affected by thalassemia in a kid-friendly, family-focused environment. We provide comprehensive treatment, offering expert clinical care, a range of support services to assist families, community outreach, education and research into the nature, causes and treatments of hemoglobin disorders.
The thalassemia program is an active participant in the NHLBI-sponsored Thalassemia Clinical Research Network (TCRN). It has been designated a “Thalassemia Treatment Center of Excellence” by the Cooley’s Anemia Foundation. We’ve also received funding from the Centers for Disease Control and Prevention (CDC) and other federal agencies to perform research studies on the prevention of blood borne infections and other complications of thalassemia, and to enhance comprehensive care.
Our program actively collaborated with the Illinois Department of Public Health to begin universal newborn screening for thalassemia starting in 2008. As a result, families are able to confirm the diagnosis and receive specialized care for their infants as early as possible to prevent complications.
What to Expect During Treatment
Most children with thalassemia require a life-long treatment of regular blood transfusions and iron chelation therapy. Complications from the disease and its treatment can include heart problems, liver damage, diabetes, infertility, growth failure and thin or deformed bones. Our specialists are trained to treat children with thalassemia, meet their specific needs and counsel all family members on preventive treatment measures and serious complications.
Our Thalassemia Care Team
- Our team of pediatric hematologists are trained in treating all types of thalassemia diagnosis. Their goal is to provide the highest quality of comprehensive care, identifying and treating complications, improving the quality of life, and offering cutting-edge treatments and curative options. You can expect to see our hematologists during your clinic visit.
- The pediatric nurse practitioner evaluates every thalassemia patient during visits for their routine transfusions under the supervision of a hematologist. You can expect to see our nurse practitioner at your transfusion visits in the Ambulatory Infusion Center.
- The nurse specialists dedicated to our thalassemia program provide continuing education and monitor compliance with chelation therapy. You will connect with our nurse specialists at clinical appointments, on the phone, and when utilizing MyChart.
- A social worker provides support regarding the diagnosis and therapy, while identifying all necessary resources available to the family. The social worker is available to all thalassemia patients at clinic visits, transfusion appointments, and inpatient admissions as needed.
- Our genetic counselor is available to answer questions, provide education, and assist with family planning from diagnosis through all life stages. Our certified genetic counselor is likely the first person you will talk to from our team. They are available at clinic visits and by phone.
- Our education liaison helps support patients with thalassemia succeed in a school setting. Patients and families can speak with the Education Liaison at clinical appointments, transfusion appointments, and during inpatient admissions.
- The program manager connects patients and families to one another, facilitates patient and family advocacy events, and communicates important information to our patients through an email list, in-person appointments, and is always available by phone. You will also spend more time with the program manager when you/your child enters healthcare transition.
- Research coordinators ensure that our thalassemia patients have access to cutting-edge treatments and novel therapies through clinical trials. You may meet one of our research coordinators at a clinic visit or over the phone. If you are enrolled in a study, you may have frequent communication with our research team.
Sherif Badawy, MD
Attending Physician, Hematology, Oncology, Neuro-Oncology & Stem Cell Transplantation; Director, Comprehensive Thalassemia Program; Associate Director, Comprehensive Sickle Cell Program
Robert I. Liem, MD
Division Head, Hematology, Oncology, Neuro-Oncology & Stem Cell Transplantation; Director, Comprehensive Sickle Cell Program; Meryl Suzanne Weiss Distinguished Professorship in Hematology, Oncology & Stem Cell Transplantation
Christina M. Barriteau, MD
Attending Physician, Hematology, Oncology, Neuro-Oncology & Stem Cell Transplantation; Medical Director, Blood Bank
Heather L. Kligfeld, DO
Attending Physician, Hematology, Oncology, Neuro-Oncology & Stem Cell Transplantation
Stephanie Matthies, APRN-NP, PNP
Pediatric Nurse Practitioner, Hematology, Oncology, Neuro-Oncology & Stem Cell Transplantation
Hannah M. Wyler, DNP, APRN
General Hematology Nurse Practitioner, Hematology, Oncology, Neuro-Oncology & Stem Cell Transplantation
Janice Rambow Beatty, RN
Thalassemia Nurse Specialist
Althea Mills, RN
Thalassemia Nurse Specialist
Kristin Clemenz, MS, CGC
Genetic Counselor III, Hematology, Oncology, Neuro-Oncology & Stem Cell Transplantation
Lauren Hearn, MEd
Education Liaison
Sarah Null, MPH
Thalassemia Program Manager
Brianna Sullivan, LSW
Social Worker, Sickle Cell & Thalassemia
Leticia Alvarado
Research Coordinator
Christa Martinez Bran
Research Coordinator
Kevin Guerrero
Research Coordinator
Christine Inguglia
Research Coordinator
Savannah Winkler
Research Coordinator
Treatment and Monitoring Options
The main symptom of thalassemia is moderate to severe anemia. Your treatment plan might include:
- Blood transfusions: Some patients with thalassemia may need regular blood transfusions to reduce the symptoms of anemia. The frequency of transfusions needed varies with each patient.
- Monitoring iron overload: Patients who receive regular transfusions can experience iron overload. Iron overload can cause complications like organ damage. It is important to monitor iron overload in thalassemia patients. We use imaging (specifically, magnetic resonance imaging (MRI)) to better understand a patient’s degree of iron overload.
- Managing iron overload: In thalassemia patients who are experiencing a high level of iron, our team will prescribe iron chelation therapy. Iron chelation helps the body to remove the extra iron that has built up in the body. There are different kinds of iron chelation treatments. Our providers will work with you to determine the best time to start iron chelation.
- Medication: Our providers may talk to you about starting a medication called luspatercept. Luspatercept is a novel therapy for Transfusion Dependent Thalassemia and may help alleviate some symptoms of anemia and reduce the volume and/or frequency of blood transfusions.
- Curative options: Lurie Children’s offers both stem cell transplantation and gene therapy as curative options. The Comprehensive Thalassemia Program works closely with the Gene and Cellular Medicine Program to offer highly specialized treatment options for thalassemia patients. To learn more about gene therapy and thalassemia, explore our gene therapy resource.
Patient and Family Events
- ‘Thal Time’ Social Outing – Annual Event in Spring
This event is purely social. It is an opportunity for patient and parents to connect with each other. Members of the Thalassemia Care Team will also be in attendance to connect one-on-one with patients and families. - Annual Thalassemia Patient & Family Day – Annual Event in Fall
The Annual Thalassemia Patient & Family Day is an inspiring and educational event dedicated to thalassemia patients, their families, advocates, and healthcare providers. The event aims to foster a deeper understanding of thalassemia, promote collaboration and education, and empower anyone involved in the journey of managing thalassemia. Participants will hear from both patients and providers on topics related to thalassemia care and healthy living. There will be activities for children of all ages, a light breakfast and lunch, and opportunities to connect with others in the community
For questions or comments about Patient and Family Events, contact Sarah Null – Program Manager at senull@luriechildrens.org.
Make an Appointment
We offer easy online scheduling for your child's hematology and oncology needs.
Our Location
Ann & Robert H. Lurie Children's Hospital of Chicago
225 E. Chicago Ave.Chicago, Illinois 60611
312.227.4000
Resources & Support
Find additional information about thalassemia at:
Thalassemia Program News & Stories
First Person with Dr. Robert Liem: APIDA Heritage Month Reflections
Dr. Robert Liem shares about meaningful professional moments and cherished personal ones in honor of APIDA Heritage Month.
Gene Therapy for Thalassemia Ends Need for Transfusions in Young Children
Clinical Trials at Lurie Children’s Benefit from Advances in Gene Therapy
Gene therapy is a way to correct harmful genetic changes. Its purpose is to give cells the right DNA instructions needed to make products that work as they should.
Philanthropy
Your support is vital in helping us continue to make a difference in the lives of patients and families. Lurie Children’s relies on philanthropic funding to enhance its programs, services and research for children. To learn more, please e-mail the Ann & Robert H. Lurie Children’s Hospital of Chicago Foundation at foundation@luriechildrens.org or call 312.227.7500.